What is rms disease kesimpta?

RMS (Relapsing-Remitting Multiple Sclerosis) is an autoimmune disease that affects the central nervous system. It is characterized by episodes of neurological symptoms followed by periods of remission. Kesimpta (ofatumumab) is a treatment for RMS that works by targeting B-cells, a type of white blood cell involved in the immune response.

Kesimpta is administered as a subcutaneous injection, typically once a month. It has been shown to reduce the frequency of relapses and delay the progression of disability in individuals with RMS. Common side effects of Kesimpta may include injection site reactions, infections, and upper respiratory tract infections.

It is important for individuals with RMS to discuss the potential benefits and risks of Kesimpta with their healthcare provider before starting treatment. Regular monitoring and follow-up appointments are typically recommended to assess its effectiveness and manage any potential side effects.